Randomized, double-blinded, active-controlled (Darbepoetin Alfa), phase 3 study of vadadustat in CKD patients with anemia on hemodialysis in Japan. Abstract TH-OR024 O
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.